Evidence map›Paper›PMID 41683572›Full record

ArticleInternational journal of molecular sciences2026

HSP25 and HSP25-P-Ser15 Prompt Innate Neuroprotection in Lobe X of the Cerebellum.

Carlos Hernández-Pérez, Laura Pérez-Revuelta, Pablo G Téllez de Meneses, Valeria L Cabedo, José Ramón Alonso, David Díaz, Eduardo Weruaga

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos Hernández-PérezLaboratory of Neuronal Plasticity and Neurorepair, Institute for Neuroscience of Castilla y León (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.
Laura Pérez-RevueltaCologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50923 Cologne, Germany.ORCID 0000-0002-9010-8220
Pablo G Téllez de MenesesLaboratory of Neuronal Plasticity and Neurorepair, Institute for Neuroscience of Castilla y León (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-2512-4619
Valeria L CabedoLaboratory of Neuronal Plasticity and Neurorepair, Institute for Neuroscience of Castilla y León (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.ORCID 0000-0002-3855-0898
José Ramón AlonsoLaboratory of Neuronal Plasticity and Neurorepair, Institute for Neuroscience of Castilla y León (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.
David DíazLaboratory of Neuronal Plasticity and Neurorepair, Institute for Neuroscience of Castilla y León (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-3705-817X
Eduardo WeruagaLaboratory of Neuronal Plasticity and Neurorepair, Institute for Neuroscience of Castilla y León (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-2887-5506

Funding

Centre for Regenerative Medicine and Cell Therapy of Castile and Leon No numberConsejería de Educación de la Junta de Castilla y León SA030P17Consejería de Educación de la Junta de Castilla y León SA112P24Consejería de Educación de la Junta de Castilla y León SA129P20MINECO SAF2016-79668-RMinisterio de Ciencia, Innovación y Universidades PID2019-106943RB-I00Ministerio de Ciencia, Innovación y Universidades PID2022-140456NB-I00Universidad de Salamanca No number
6 · The paper itself

Abstract

The cerebellar cortex presents a repetitive structure, but the main projecting neurons of this tissue, the Purkinje cells, are not identical and behave differently to various types of injury. Common patterns of neurodegeneration exist, where certain Purkinje cells die earlier than others. By contrast, lobe X of the cerebellum is a particularly resistant structure, independently of the cerebellar disease or damage. However, the mechanisms underlying the survival capability of these especially resistant Purkinje cells are still unknown. In this work, we have used the Purkinje Cell Degeneration (PCD) mouse, a model of severe cerebellar degeneration that also reproduces the human disease called childhood-onset neurodegeneration with cerebellar atrophy, to study Purkinje cell resistance. After an exhaustive immunochemical analysis of the different subpopulations of Purkinje cells, the Heat Shock Protein 25 (HSP25) and its phosphorylated version HSP25-P-Ser15 were found to be especially induced in lobe X of PCD mice. As this protein has neuroprotective properties, it may be responsible for resistance against cerebellar neurodegeneration. Taking into account the constant resistance of lobe X, the use of HSP25 may lead to new possibilities for achieving natural protection both in cerebellum and in other brain structures, or even for developing future neuroprotective therapies.

Indexed as

CerebellumHeat-Shock ProteinsNeuroprotectionPurkinje CellsAnimalsDisease Models, AnimalMiceMolecular ChaperonesPhosphorylationHeat-Shock ProteinsHsbp1 protein, mouseMolecular Chaperonescerebellar lobescerebellumCONDCAHSPneuroresistancePurkinje Cell Degeneration

Identifiers

PMID41683572
PMCPMC12897430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.